Literature DB >> 12855946

Update: cardiac and other adverse events following civilian smallpox vaccination--United States, 2003.

.   

Abstract

During January 24-June 20, 2003, smallpox vaccine was administered to 37,802 civilian health-care and public health workers in 55 jurisdictions to prepare the United States for a possible terrorist attack using smallpox virus. This report updates information on vaccine-associated adverse events among civilians vaccinated since the beginning of the program and among contacts of vaccinees, received by CDC from the Vaccine Adverse Event Reporting System (VAERS) as of June 20. Two cases of dilated cardiomyopathy (DCM) were diagnosed 3 months after vaccination. For the potential relation between smallpox vaccine and DCM to be assessed, identification of additional cases of DCM among vaccinees will be essential. Physicians who treat smallpox vaccine recipients are encouraged to evaluate and report patients with symptoms compatible with DCM, including those that occur several months after vaccination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12855946

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety.

Authors:  Peter I Folb; Ewa Bernatowska; Robert Chen; John Clemens; Alex N O Dodoo; Susan S Ellenberg; C Patrick Farrington; T Jacob John; Paul-Henri Lambert; Noni E Macdonald; Elizabeth Miller; David Salisbury; Heinz-J Schmitt; Claire-Anne Siegrist; Omala Wimalaratne
Journal:  Am J Public Health       Date:  2004-11       Impact factor: 9.308

2.  Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection.

Authors:  Jeffry D Shearer; Linda Siemann; Mary Gerkovich; Robert V House
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 3.  The heart and SARS-CoV-2.

Authors:  David González-Calle; Rocío Eiros; Pedro L Sánchez
Journal:  Med Clin (Barc)       Date:  2022-07-20       Impact factor: 3.200

Review 4.  ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Authors:  Thomas P Monath; Joseph R Caldwell; Wolfgang Mundt; Joan Fusco; Casey S Johnson; Mark Buller; Jian Liu; Bridget Gardner; Greg Downing; Paul S Blum; Tracy Kemp; Richard Nichols; Richard Weltzin
Journal:  Int J Infect Dis       Date:  2004-10       Impact factor: 3.623

Review 5.  The heart and SARS-CoV-2.

Authors:  David González-Calle; Rocío Eiros; Pedro L Sánchez
Journal:  Med Clin (Engl Ed)       Date:  2022-10-14

Review 6.  Surveillance and control measures during smallpox outbreaks.

Authors:  Emma Kerrod; Alasdair M Geddes; Martyn Regan; Steve Leach
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

Review 7.  The risks and benefits of pre-event smallpox vaccination: where you stand depends on where you sit.

Authors:  Tomás J Aragón; Susan E Fernyak
Journal:  Ann Emerg Med       Date:  2003-11       Impact factor: 5.721

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.